Urology Private Equity | Market Update Fall 2022 | PGP

Urology Private Equity – Market Update

Fall 2022

In the past three years consolidation within urology has shifted from nascent in nature to a pervasive force across the specialty, and it now serves as one of the most rapidly consolidating specialties in healthcare. Unlike earlier consolidation waves within dermatology, eye care, and dental, the dynamics of the urology space (large, independent group practices, deep shareholder bases, national connectivity through LUGPA) coupled with the rapid pace of activity has prevented many new private equity-backed platforms from forming. Instead of 30-40+ active platforms as we’ve seen in some other specialties, we only see eight true players in urology.

Additionally, in terms of market saturation and maturation, what took seven years to happen within dermatology and eye care has taken only three years within urology. The result of these market realities is a tightening window for independent groups to move on their own volition. Another unique component of urology consolidation is the creation of physician-led MSO models that serve as a private equity alternative. These physician-led groups have started to become a viable option for independent practices, but offer an entirely different set of pros and cons.

We expect urology consolidation to continue at a strong pace throughout 2023 despite changing economic conditions. While the opportunity to be a first mover has passed, independent groups now have the benefit of evaluating platforms with a proven track record. And while the opportunity for practices to partner with best-in-class MSOs isn’t going anywhere, ongoing, rapid consolidation will lead to continually changing dynamics that need to be considered.  

Interested in how private equity can be helpful in your practice?

Recent Transaction Activity in Urology

DateTargetPlatformPE Sponsor
September 2022The Ross Center *Thurston GroupARC Health
August 2022Brookedale Premier Addition RecoveryWebster Equity PartnersDiscovery Behavioral Health
August 2022The Incredible YearsNorthlane Capital PartnersEmpower Community Care
August 2022Column HealthShore Capital PartnersBrightView Health
August 2022Action Behavior CentersCharlesbank Capital PartnersCharlesbank Capital Partners
August 2022Southeast PsychThurston GroupARC Health
August 2022SpringstoneApollo ManagementLifePoint Health
August 2022Monte Nido & AffiliatesRevelstoke Capital PartnersRevelstoke Capital Partners
August 2022Psych360*WP Global PartnersMindCare Solutions Group
July 2022Sandstone CareThe Vistria GroupThe Vistria Group
July 2022Monte Nido & AffiliatesRevelstoke Capital PartnersRevelstoke Capital Partners
July 2022Hallmark YouthcarePetra Capital PartnersAcute Behavioral Health
July 2022A New Era TMS & PsychiatryWebster Equity PartnersDiscovery Behavioral Health
July 2022San Antonio Recovery CenterWebster Equity PartnersBayMark Health Services
July 2022Center or Behavioral, Educational & Social TherapyFive Arrows Capital PartnersThe Stepping Stones Group
*These Targets were advised by Physician Growth Partners

About Physician Growth Partners

  • Physician Growth Partners (PGP) is a transaction advisory firm that represents independent physician groups working with private equity
  • We are Healthcare Transaction Advisors differentiated by:
  • Senior partner involvement at every stage of the process
  • Extensive physician practice transaction experience
  • Unmatched relationships with all key private equity and strategic buyers interested in urology
  • Educational approach focused on partnership and cultural fit, while achieving a market clearing valuation

Our Recent Urology Transaction Expertise

Urology associates transaction
CSUA has partnered wih Solaris transaction
Urology associates transaction
Urology Austin has partnered with Gauge Capital

Learn More About Urology Private Equity